Dsm-firmenich, a global specialist in nutrition, health and beauty innovation, held its Capital Markets Day (CMD) in Paris on June 3, 2024. At this event, the company presented its strategy to investors and analysts, as well as its capabilities in science, innovation and creation.
The CMD discussed how the company is implementing its strategy. These included the merger, the company's focus on high-margin, high-growth activities, and the acceleration of its development.
"Our journey began with a bold dream and a vision to bring progress to life by combining the essential, the desirable and the sustainable. We combined the strengths of two iconic companies to create dsm-firmenich, a global leader in nutrition, health and beauty, able to help customers deliver what consumers want, what we collectively need and what our planet demands. Against the backdrop of a challenging 2023, (...) we have decided to de-prioritize certain business segments, and our way forward is guided by a finely-tuned strategy that prioritizes high-growth, high-margin segments in nutrition, health and beauty."commented Dimitri de Vreeze, CEO of dsm-firmenich.
Dsm-firmenich invests in science and research to innovate, with a focus on sustainable development. The four areas of research are: biotech, microbiome, receptor biology and sensory sciences, and data science and artificial intelligence.
In its new configuration, dsm-firmenich will comprise three complementary business units: "Perfumery & Beauty", "Taste, Texture & Health" and "Health, Nutrition & Care".
Medium-term objectives include sales growth of 5 to 7 %.
Photo: Screenshot of the conference, featuring Dimitri de Vreeze, CEO of dsm-firmenich.
